GlassScriptPhysician profile
Noreen Anwar
NPI 1679096176
$2,605.66
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,061 · 2020: $45.08 · 2021: $268 · 2022: $166 · 2023: $65.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,156.97 | 2019-2021 | |
| Orthofix Medical, INC. | $700.73 | 2019 | |
| Medical Device Business Services, INC. | $319.99 | 2019 | |
| Integra Lifesciences Corporation | $130.19 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $78.37 | 2021-2022 | |
| Amgen INC. | $66.21 | 2021-2023 | Lumakras |
| In2bones USA, LLC | $40.58 | 2021 | |
| Daiichi Sankyo INC. | $22.14 | 2021 | |
| Ibsa Pharma INC. | $18.35 | 2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $16.72 | 2022 | |
| Seagen INC. | $15.79 | 2021 | |
| Insulet Corporation | $15.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.06 | 2022 | |
| Kerecis Limited | $11.95 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noreen Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.